BlackRock Health Sciences Trust Files 8-K
Ticker: BME · Form: 8-K · Filed: Jan 21, 2025
Sentiment: neutral
Topics: 8-K, reporting, financials
Related Tickers: BHST
TL;DR
BHST filed an 8-K on Jan 21st for events on Jan 20th. Standard reporting.
AI Summary
BlackRock Health Sciences Trust filed an 8-K on January 21, 2025, reporting events as of January 20, 2025. The filing is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. It includes information on financial statements and exhibits, and other events.
Why It Matters
This filing indicates a routine update or event for the BlackRock Health Sciences Trust, providing transparency to investors regarding its operations and financial reporting.
Risk Assessment
Risk Level: low — This is a standard 8-K filing for a public company, typically reporting routine events or financial updates, and does not inherently signal significant risk.
Key Players & Entities
- BlackRock Health Sciences Trust (company) — Registrant
- Securities Exchange Act of 1934 (legal_document) — Governing regulation
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose is to report current information as required by Section 13 or 15(d) of the Securities Exchange Act of 1934, specifically noting 'Other Events' and 'Financial Statements and Exhibits'.
What is the reporting date for this filing?
The date of the report is January 21, 2025, and the earliest event reported is January 20, 2025.
What is the company's central index key?
The company's central index key is 0001314966.
Where is BlackRock Health Sciences Trust incorporated?
BlackRock Health Sciences Trust is incorporated in Delaware.
What is the principal executive office address?
The principal executive office is located at 50 Hudson Yards, New York, New York 10001.
Filing Stats: 425 words · 2 min read · ~1 pages · Grade level 11.7 · Accepted 2025-01-21 08:51:56
Filing Documents
- d901098d8k.htm (8-K) — 20KB
- d901098dex101.htm (EX-10.1) — 53KB
- 0001193125-25-009173.txt ( ) — 189KB
- ck0001314966-20250120.xsd (EX-101.SCH) — 2KB
- ck0001314966-20250120_lab.xml (EX-101.LAB) — 14KB
- ck0001314966-20250120_pre.xml (EX-101.PRE) — 9KB
- d901098d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 10.1 Standstill Agreement dated January 20, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). - 2 -
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BLACKROCK HEALTH SCIENCES TRUST By: /S/ JANEY AHN Name: Janey Ahn Title: Secretary DATE: January 21, 2025 - 3 -